Medical Properties Trust (NYSE:MPW) Stock Price Up 5.1% – Still a Buy?

Medical Properties Trust, Inc. (NYSE:MPW)’s stock price was up 5.1% during mid-day trading on Tuesday . The company traded as high as $3.92 and last traded at $3.91. Approximately 3,632,964 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 16,259,793 shares. The stock had previously closed at $3.72.

Analyst Ratings Changes

MPW has been the subject of several recent analyst reports. Truist Financial lowered their price target on Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating for the company in a report on Thursday, December 19th. Mizuho dropped their target price on shares of Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Thursday, December 5th. Colliers Securities raised shares of Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price target on the stock in a research note on Friday, September 13th. Finally, Wolfe Research raised shares of Medical Properties Trust to a “hold” rating in a research report on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Medical Properties Trust presently has a consensus rating of “Hold” and a consensus target price of $4.92.

Medical Properties Trust Stock Up 6.2 %

The firm’s 50 day simple moving average is $4.25 and its 200-day simple moving average is $4.69. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 1.69. The stock has a market capitalization of $2.37 billion, a price-to-earnings ratio of -0.94, a price-to-earnings-growth ratio of 0.62 and a beta of 1.29.

Medical Properties Trust Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 9th. Investors of record on Thursday, December 12th will be issued a dividend of $0.08 per share. The ex-dividend date of this dividend is Thursday, December 12th. This represents a $0.32 annualized dividend and a yield of 8.10%. Medical Properties Trust’s payout ratio is presently -7.58%.

Insider Buying and Selling at Medical Properties Trust

In related news, Director Michael G. Stewart sold 32,780 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $5.46, for a total value of $178,978.80. Following the completion of the sale, the director now directly owns 221,245 shares in the company, valued at approximately $1,207,997.70. This trade represents a 12.90 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO James Kevin Hanna sold 11,641 shares of Medical Properties Trust stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $3.72, for a total value of $43,304.52. Following the transaction, the chief accounting officer now owns 366,913 shares of the company’s stock, valued at $1,364,916.36. The trade was a 3.08 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 47,421 shares of company stock worth $233,293 over the last ninety days. 1.53% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Dimensional Fund Advisors LP lifted its holdings in Medical Properties Trust by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 8,622,683 shares of the real estate investment trust’s stock valued at $37,168,000 after purchasing an additional 328,184 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Medical Properties Trust by 22.6% in the second quarter. Bank of New York Mellon Corp now owns 6,908,362 shares of the real estate investment trust’s stock valued at $29,775,000 after purchasing an additional 1,274,481 shares during the period. Silver Point Capital L.P. lifted its stake in shares of Medical Properties Trust by 155.3% during the 3rd quarter. Silver Point Capital L.P. now owns 6,000,000 shares of the real estate investment trust’s stock worth $35,100,000 after buying an additional 3,650,000 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Medical Properties Trust by 353.5% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust’s stock worth $20,625,000 after buying an additional 2,748,245 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in Medical Properties Trust by 21.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,704,785 shares of the real estate investment trust’s stock valued at $9,973,000 after buying an additional 303,628 shares during the last quarter. 71.79% of the stock is currently owned by institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.